CONTACT:
Jud Hall
877.443.4006
Infusion care provider highlights importance of safe and cost-effective options for immunoglobulin treatment
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12th National Conference, which takes place on October 5th – 8th in Denver, Colorado. The annual conference provides a forum for industry leaders across multiple disciplines to explore major therapy updates, clinical management, standards of practice, and expert workshops.
By providing a team-based approach to intravenous immunoglobulin (IVIG) therapy, AIC delivers specialized treatment options to individuals living with immunodeficiencies and other complex conditions. For these patients, IVIG is used to manage various immunodeficiency states and other conditions, including autoimmune, infectious, and other inflammatory ailments. The ultimate goal of this therapy is to normalize a compromised immune system, fight infections, and have patients receive care in the comfort of their own homes.
This year at IgNS, AIC representatives will present their analysis of policy changes to reduce the overall infusion escalation time for patients with a 10% intravenous immunoglobulin product.
“At AIC, we are constantly innovating to ensure that our infusion care services best meet the needs of our patients. The Immunoglobulin National Society’s annual conference is an important venue for AIC and other leaders to come together to advance our industry, share best practices, and deliver the best possible care for patients,” said Jud Hall, President at AIC.
The specialty pharmacy provider traditionally follows a policy of increasing IVIG infusion rates every 30 minutes. To accommodate patient preferences and changing healthcare reimbursement practices, AIC reevaluated this infusion policy to explore the possibility of reducing the overall infusion time per patient and identify more cost-effective and safe options for IVIG administration.
AIC’s retrospective review of some patient records over a six-month period showed that 11 of the 13 observed patients reported no adverse experiences with two patients reporting adverse experiences across 70 infusions (2.9% incidence). Patients also reported satisfaction with the new shorter infusion rate of 15 minutes for 68 out of the 70 infusions. The analysis also saw a mean reduction of 41.7 minutes (23.9% per visit) in IVIG infusion time with the transition to the 15-minute escalation protocol leading to a reduction in the per visit cost of nursing services.
On Saturday, October 7th, AIC will present their findings to IgNS attendees during a poster board session, where experts will demonstrate how a reduction in infusion time could positively impact nursing costs, patient quality of life, and infusion-related adverse event occurrence. AIC’s analysis indicates the change in policy resulted in well-tolerated and shorter infusion times which may have a positive impact on patient quality of life and healthcare resource utilization.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further distinguishing itself as an infusion services provider. AIC is also a member of IgNS and is regularly inspected by national and state boards of pharmacy.
In recent months, AIC announced the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC also made medications like GAMMAKED™ and LEQEMBI™ available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, announced its participation in the National Association of Specialty Pharmacy (NASP) 2023 Annual Meeting and Expo, which took place on September 18th – 21st in Grapevine, Texas. At the NASP 2023 Annual Meeting and Expo, AIS Healthcare sponsored a continuing education symposium through an unrestricted educational grant that focused on the critical topic of USP 797 guideline revisions, a set of standards developed by U.S. Pharmacopeia (USP) governing the safe compounding of sterile preparations in healthcare settings, and its impact on the healthcare industry. These topics were discussed during panel discussions with industry experts and led by Katrina K. Harper, Director of Clinical Education, AIS Healthcare.
AIS Healthcare’s symposium, The 411 Before 911 on USP 797: Changes, Challenges, and Choices, featured speakers including:
AIS Healthcare is dedicated to advancing best practices across the specialty pharmacy industry. The NASP Annual Meeting and Expo served as a crucial platform for industry leaders to come together to promote the highest standards of sterility, quality, and safety in the development of compounded medications.
“Advancing quality and improving lives is at the center of what this event is about. The NASP 2023 Annual Meeting and Expo provided an important setting for experts within our industry to engage and learn from one another with the goal of best serving our patients’ unique needs. We were proud to facilitate important discussions about how we prioritize sterility, quality, and safety in all the medications we produce for patients,” said Simon Castellanos, CEO of AIS Healthcare.
USP 797 revisions become official and enforceable on November 1, 2023. Pharmacies preparing Category 3 compounded sterile preparations (CSPs), formerly known as high-risk preparations, now face more rigorous standards. These revisions will require increased staffing, training, and investment, all of which may pose challenges for pharmacies. AIS Healthcare is already meeting or exceeding these revised standards.
AIS Healthcare is honored to have participated in the NASP 2023 Annual Meeting and Expo and is committed to fostering innovation and excellence in pharmaceutical compounding. For more information about the NASP 2023 Annual Meeting and Expo, please visit www.naspmeeting.com.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September 17th as World Patient Safety Day. Throughout its TDD and infusion care divisions, AIS Healthcare is committed to advancing quality and improving the lives of patients with a focus on safety and well-being.
Established in 2019 by the World Health Organization (WHO), World Patient Safety Day brings together patients, families, caregivers, nurses, and healthcare leaders to show their commitment to patient safety. AIS Healthcare reaffirms its pledge to continue exceeding industry standards to produce medications of the highest quality and sterility for individuals living with complex medical conditions. For in-home immunoglobulin therapy infusion and intrathecal pump medication delivery and maintenance, AIS Healthcare’s highly skilled nursing and pharmacy teams provide specialized care that leads to better patient outcomes.
World Patient Safety Day calls attention to the supreme importance of patient safety. “We believe that true progress in healthcare begins with patient safety as its foundation,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our commitment to enhancing patient well-being through innovative solutions is unwavering. At AIS Healthcare, we strive to raise the bar across our industry to ensure patients have absolute trust in the safety and quality of their medications and services.”
Across its TDD division, AIS Healthcare ships more than 140,000 patient-specific prescriptions annually to all 50 states for patients managing chronic pain and complex medical conditions. Throughout its operations, AIS Healthcare goes beyond industry and state-level standards to produce medications of the highest safety and quality.
AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), distinguishing itself as an industry leader in targeted drug delivery and infusion care. In observance of World Patient Safety Day, AIS Healthcare remains dedicated to delivering transformative services across the care continuum, consistently prioritizing patient safety and well-being.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Simon Castellanos
877.443.4006
AIS Healthcare reaffirms commitment to improving the lives of patients living with chronic pain
Dallas, TX – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September as Pain Awareness Month. Throughout this month, AIS Healthcare aims to raise awareness about the challenges faced by individuals living with chronic pain and highlight the importance of accessible and effective pain management solutions. In the United States, chronic pain is a widespread issue affecting more than 51 million Americans. AIS Healthcare serves some of the most vulnerable chronic pain patients through TDD, offering patients customized medications from our state-of-the-art pharmacies and care from highly trained nursing staff across the country.
Our cutting-edge treatment empowers patients to manage their pain effectively and lead full and active lives. As a leading provider in the pain management field, AIS Healthcare goes beyond traditional methods, offering innovative and compassionate solutions that aim to bring relief to those who need it most. During Pain Awareness Month and beyond, AIS Healthcare is committed to raising standards of care, quality, and safety across the industry to positively impact our patients’ quality of life.
“We pride ourselves on supporting patients to live with less pain, enabling them to be fully present and active with their families and in their communities. Our state-of-the-art quality and safety standards are critical to alleviating the burden of pain for our patients and restoring hope for those managing chronic conditions,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our approach goes beyond merely addressing the physical aspects of pain; we recognize the emotional toll it takes on individuals and their families.By consistently raising the bar for excellence in targeted drug delivery and infusion care, we can truly transform our patients’ lives by dramatically improving their quality of life.”
Since being established in 2008, AIS Healthcare has been delivering care that puts patients first. At every step of a patient’s care, AIS Healthcare aims to be a supportive partner by delivering customized medications and personalized services while ensuring the patient’s emotional and psychological well-being are cared for as well.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. AIS Healthcare continues to deliver transformative services across the care continuum for its patients.
About AIS Healthcare
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
CONTACT:
Jud Hall
877.443.4006
AIC’s new pharmacy will better serve patients and physicians across the Mid-Atlantic
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced the opening of a new pharmacy location in Cockeysville, Maryland. This continued expansion to the Northeast provides a platform for the company to serve more patients and physicians in the region. The Maryland pharmacy is AIC’s sixth location from which the company dispenses essential medications and personalized care to patients across the United States with complex medical conditions like immune deficiency diseases.
The newly opened pharmacy is strategically positioned and designed to cater to the unique needs of patients and providers in the Mid-Atlantic. With a firm commitment to elevating the patient experience, AIC aims to make medications and home infusion services more accessible to those in need of care solutions.
“We are thrilled to open a pharmacy location in Maryland. This expansion is a testament to AIC’s unwavering dedication to our patients and our vision of providing best-in-class healthcare services with a personal touch. By opening this location, we aim to streamline the medication fulfillment process, enhance convenience, and ultimately improve the lives of our patients,” said Jud Hall, President at AIC.
With a focus on efficiency and compassion, AIC is committed to addressing the unique medication needs of each patient and fostering strong relationships with healthcare providers in the area. The fully operational pharmacy in Maryland has started dispensing its extensive inventory of prescription medications, over-the-counter products, and specialty medications to patients. The location utilizes cutting-edge technology and a team of highly skilled pharmacists and healthcare professionals to serve patients. The facility also features a state-of-the-art USP797-compliant cleanroom which is critical to ensuring sterility and quality in the medications.
In recent months, AIC announced further expansion into the New England market and the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC also made medications like GAMMAKED™ and LEQEMBI™ available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Advanced Infusion Care’s Nurse Specialists and In-Home Infusion Care Offerings Extended to Cover Connecticut, Massachusetts, and Rhode Island
Dallas, TX – Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced the expansion of its nurse specialists and in-home infusion care offerings to Connecticut, Massachusetts, and Rhode Island. With its expansion to cover more of the New England market, AIC’s network of 180 nurses is now present in 40 states. AIC’s pharmacists and nursing team will offer a comprehensive suite of medications and services for patients with complex medical conditions like immune deficiency diseases.
By providing a team-based approach to intravenous and subcutaneous immunoglobulin (Ig) therapy, AIC delivers specialized treatment options to individuals living with immunodeficiencies and other complex conditions. For these patients, Ig therapy enables them to fight infections, stay healthy, and receive care in the comfort of their own homes. All patients in the expanded territory will have access to 24/7 nurse availability for education, care coordination, medication management, and more.
“Our growth into the New England market will allow AIC’s talented team of infusion nurse specialists to support even more patients,” said Jud Hall, President at AIC. “Our team of nationally accredited home infusion specialists will help ensure each individual’s specific clinical and personal needs are met, driving better outcomes for all of our patients.”
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. AIC is also a member of the Immunoglobulin National Society and is regularly inspected by national and state boards of pharmacy.
In recent months, AIC announced the grand reopening of a newly designed pharmacy in Valdosta, Georgia. AIC continues to add cutting edge medications available to patients through its locations in Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; and Dallas, Texas.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Targeted drug delivery and infusion care solutions improve patient quality of life and increase physical activity to promote health and wellness among seniors
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, recognizes today as the 30th annual National Senior Health & Fitness Day. The medication and services provided by AIS Healthcare Targeted Drug Delivery (TDD) and Advanced Infusion Care (AIC) empower seniors to live healthy and productive lives by helping manage severe pain, spasticity, and other chronic health conditions. National Senior Health & Fitness Day, celebrated on the last Wednesday of May, is a day dedicated to the wellness of seniors with the common goal of helping keep American seniors fit and healthy.
Seniors utilizing TDD through AIS Healthcare report improvement with their pain, spasticity, physical functionality, and quality of life. The goal of the therapy is to minimize pain and allow patients to regain their ability to participate in daily activities. Patients managing chronic pain and spasticity represent an extremely high-risk group prone to hospitalization, urgent care visits, and surgeries that often fail.
At AIC, a division of AIS Healthcare, infusion therapies help treat patients with a range of medical conditions including primary immunodeficiency, lung problems, and autoimmune diseases. For seniors living with these conditions, infusion therapies help to manage their treatments effectively and live a full life.
“Our patients are at the center of everything we do. At AIS Healthcare, we strive to meet the highest standards of safety and quality in our medications and services so that we meaningfully improve the lives of all our patients. We are committed to providing seniors with best-in-class care that increases their physical activity and improves their overall health and wellness,” said Simon Castellanos, AIS Healthcare Chief Executive Officer.
National Senior Health & Fitness Day is the largest health and wellness movement for seniors in the U.S., celebrated across senior centers, hospitals, health clubs, retirement communities, and more. This May 31, 2023, marks a time to celebrate the contributions of seniors to our communities and renew our efforts to keep them healthy and thriving.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is proud to recognize May 6th – 12th as National Nurses Week. National Nurses Week brings attention to four focus areas — Self-Care, Recognition, Professional Development, and Community Engagement. AIS Healthcare honors the contributions, dedication, and sacrifices of these critical medical professionals as they work to improve the lives of their patients.
“I express the company’s utmost gratitude and respect for all the nurses at AIS Healthcare who serve our patients diligently. The services we provide to our patients would not be possible without the hard work and dedication of our nursing staff. Across the country, AIS Healthcare’s nurses offer comprehensive care services that improve their patients’ quality of life. We celebrate our team’s contributions during Nurses’ Week, and every week,” said Pam Carter, AIS Healthcare’s Chief Nursing Officer.
Nurses conduct some of the most difficult work in the healthcare industry, performing essential tasks and serving as the first point of contact for many patients. AIS Healthcare celebrates the more than 250 nurses on our staff that play an important role in advancing quality and improving outcomes for our patients.
Advancements in science and medical technology have dramatically expanded the role of nurses in the healthcare system. Recent crises, particularly the COVID-19 pandemic, have also underscored the crucial role nurses play both in the healthcare industry and in society. From emergency response to caring for the elderly and newborn, nurses perform some of the most difficult tasks in the medical world.
Their service to patients is commended during this National Nurses Week and throughout the year. To learn more about National Nurses Month and Week please visit the American Nurses Association website here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Contact:
Simon Castellanos
877.443.4006
Thomas Young to serve as AIS Healthcare’s Deputy General Counsel and Deputy Chief Compliance Officer
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, today announced the hiring of Thomas Young as Deputy General Counsel and Deputy Chief Compliance Officer. In this role, Thomas will drive AIS Healthcare’s legal strategy, help oversee the company’s regulatory and compliance programs, and lead engagement with state and federal regulators.
“We are thrilled to welcome an experienced and highly respected member of the healthcare industry to the AIS Healthcare team,” said John Finley, AIS Healthcare’s General Counsel and Chief Compliance Officer. “Thomas will bring a valuable perspective to the company and serve as a trusted advisor as we continue to raise the bar for delivering the safest and highest-quality care to our patients.”
Young brings more than 30 years of executive experience in the healthcare industry to AIS Healthcare with a focus on navigating complex regulatory environments. Recently, Young served in a senior role at Cigna Health as the company’s Medicare Compliance Officer. Previously, Young spent over 25 years at Aetna Health where he served in various compliance and regulatory roles, including Chief Compliance Officer.
“I’m excited to join AIS Healthcare’s industry leading team and offer my experience to further enhance the company’s efforts to advance quality and compliance standards for specialty pharmacies,” said Thomas Young, AIS Healthcare’s Deputy General Counsel and Deputy Chief Compliance Officer. “I’m proud to be part of a team that is committed to offering the safest and highest-quality treatments and services to dramatically improve the lives of patients suffering from severe chronic pain, spasticity, and immunodeficiency diseases.”
Young holds a J.D. from Duke University’s School of Law and an undergraduate degree from Princeton University.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
We are pleased to announce that Natalie DeGroff, MS, RN, FNP-C, our Senior Director of Targeted Drug Delivery (TDD) Nursing Operations, has been selected as one of the 14 qualified nurse practitioners (NPs) for the American Association of Nurse Practitioners (AANP) Executive Leadership Program Cohort. This program helps high-potential NPs develop a strategic mindset and multiply their impact as leaders across their organizations.
Natalie brings more than 16 years of experience to her role at AIS Healthcare. Previously a pain management NP, she has worked in hospital, ambulatory, health call center, home infusion and specialty pharmacy settings. Natalie is an invaluable member of the AIS Healthcare team and her selection to the AANP reflects her exemplary work ethic in the TDD landscape.
“Natalie is a proven, versatile, and engaging leader,” said Pam Carter, Chief Nursing Officer at AIS Healthcare. “AIS Healthcare is fortunate to have nursing leadership of this caliber. This is a well-deserved recognition and accomplishment for Natalie.”
The American Association of Nurse Practitioners® (AANP) is the largest professional membership organization for NPs of specialties. It represents the interests of more than 355,000 licensed NPs in the U.S. The AANP advances health policy through legislative leadership at the local, state, and national levels; promotes excellence in practice, education, and research; and builds standards that best serve NPs’ patients and other healthcare consumers.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.